期刊文献+

甲状腺素与慢性阻塞性肺疾病患者病情与预后关系 被引量:4

The relationship between thyroxine and COPD patients′ conditions and prognostic
下载PDF
导出
摘要 目的根据血清甲状腺激素的变化来评估慢性阻塞性肺病患者的病情与预后。方法对90例健康者(对照组)和125例COPD患者(缓解期、急性加重期无呼衰、急性加重期伴呼衰)进行TT3、FT3、TT4、FT4和TSH水平的检测并对数据进行分析。结果 COPD缓解期甲状腺激素水平与对照组比较,差异无显著性;AECOPD甲状腺激素水平与对照组及COPD缓解期组比较均降低,有显著性差异,其中呼衰组下降最低。结论甲状腺素水平的变化与COPD病情严重程度及预后相关,血清中甲状腺素水平可用于COPD的病情与预后的评估。 Objective To assess the COPD patients' conditions and prognostic based on the serum thyroid hormone levels change. Methods The data of 90 non-COPD patients as the control group and 125 COPD patients including their remission stage, acute exacerbations stage, acute exacerbations and respiratory failure stage were detected and analyzed at the level of TT3, F33, TY4, FT4 and TSH. R^ults There was no significant difference between the COPD patients ( stable stage) and the control group. The thyroid hormone level of AECOPD patients was lower than the control group and COPD (stable stage) with significant difference, whereas the thyroid hor- mone level of COPD patients ( acute exacerbations and respiratory failure stage) decreased the most. Conclusion As the change of thy- roxine levels in COPD patients is related to the COPD Patients' conditions and prognostic, the serum thyroid hormone levels change can be used to assess the COPD Patients' conditions and prognostic.
出处 《临床肺科杂志》 2012年第11期2003-2004,共2页 Journal of Clinical Pulmonary Medicine
关键词 甲状腺激素 慢性阻塞性肺疾病 预后 thyroid hormone COPD prognostic
  • 相关文献

参考文献4

二级参考文献9

  • 1白春学.慢性阻塞性肺疾病研究逐渐深入,前景日趋光明[J].中华医学杂志,2006,86(41):2881-2883. 被引量:7
  • 2Raherison C. Epidemiology of chronic obstructive pulmonary dis ease. Presse Med, 2009,38: 400-405.
  • 3Turino GM. Comorbidities, patient knowledge, and disease man agement in a national sample of patients with COPD. Am J Med, 2009,122: 348-355.
  • 4Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2007,176: 532-555.
  • 5Stanbrook MB. Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications. Evid Based Med, 2009,14: 42-43.
  • 6Barr RG, Celli BR, Mannino DM, et al. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med, 2009,360: 1329-1335.
  • 7Stevenson CS, Koch LG, Britton SL. Aerobic capacity, oxidant stress, and chronic obstructive pulmonary disease-a new take on an old hypothesis. Pharmacol Ther, 2006,110: 71-182.
  • 8柳涛,王保法,王晓红,马俊义,肖兰英,袁亚冬.甘草对慢性阻塞性肺疾病患者糖皮质激素受体的影响[J].中华结核和呼吸杂志,1999,22(10):595-597. 被引量:37
  • 9杨华,祝筱姬.慢性阻塞性肺病和肺心病患者甲状腺激素的变化及机制[J].中华临床医药杂志(北京),2003,4(24):83-84. 被引量:25

共引文献5

同被引文献30

  • 1姜辉,俞森洋.临床肺感染评分诊断通气机相关肺炎[J].中华医院感染学杂志,2005,15(7):751-752. 被引量:37
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3Mancini A,Corbo GM, Gaballo A, et al. Relationship betweenplasma antioxidants and thyroid hormones in chronic obstruc-tive pulmonary disease [J]. Exp Clin Endocrinol Diabetes,2012,12(10):623-628.
  • 4Akbas T, Karakurt S, Unluguzel G, et al. The endocrinologicchanges in critically ill chronic obstructive pulmonary diseasepatients[J]. COPD,2010,7(4):240-247.
  • 5Matos GA,Bruin PF,Bruin VM,et al. Melatonin reduces lungoxidative stress in patients with chronic obstructive pulmonarydisease; a randomized, double-blind, placebo-controlled study[J]. J Pineal Res, 2012,53 (3) : 238-244.
  • 6Bratas O, Espnes GA, Rannestad T,et al. Relapse of healthrelated quality of life and psychological health in patients withchronic obstructive pulmonary disease 6 months after rehabili-tation[J]. Scand J Caring Sci.2012,26(2) :219-227.
  • 7Dimopoulou I, Ilias I, Mastorakos G, et al. Effects of severity of chronic obstructive pulmonary disease on thyroid function[ J . Metabolism,2001; 50(12) :1397-401.
  • 8Schilling JU,Zimmermann T,Albrecht S,et al.Low T3syndrome in multiple trauma patients phenomenon or important pathogenetic factor[J].Med Klin,1999,94(1):66.
  • 9Klemperer JD,Ojamaa K,Klelin I.Thyroid hormone therapy in cardiovascular disease[J].Prog Cardiovasc Dis,1996,38(4):329.
  • 10Okutan O,Kartaloglu Z,Onde ME,et al.Pulmonary function tests and thyroid hormone concentrations in patients with chronic obstructive pulmonary disease[J].Med Princ Pract,2004,13(3):126-128.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部